NEFL and amyotrophic lateral sclerosis: The results demonstrated significantly more elevated levels of serum NFL in patients with ALS than in the HCs, and the serum NFL levels were significantly higher in rapidly progressive ALS and patients in Stage 3 than in slowly progressive ALS and patients in Stage 2.